RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 등재정보
        • 학술지명
        • 주제분류
        • 발행연도
        • 작성언어
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Delay Dependent Local Stabilization Conditions for Time-delay Nonlinear Discrete-time Systems Using Takagi-Sugeno Models

        Luís F. P. Silva,Valter J. S. Leite,Eugênio B. Castelan,Gang Feng 제어·로봇·시스템학회 2018 International Journal of Control, Automation, and Vol.16 No.3

        We propose convex conditions for stabilization of nonlinear discrete-time systems with time-varying delay in states through a fuzzy Takagi-Sugeno (T-S) modeling. These conditions are developed from a fuzzy Lyapunov-Krasovskii function and they are formulated in terms of linear matrix inequalities (LMIs). The results can be applied to a class of nonlinear systems that can be exactly represented by T-S fuzzy models inside a specific region called the region of validity. As a consequence, we need to provide an estimate of the set of safe initial conditions called the region of attraction such that the closed-loop trajectories starting in this set are assured to remain in the region of validity and to converge asymptotically to the origin. The estimate of the region of attraction is done with the aid of two sets: one dealing with the current state, and the other concerning the delayed states. Then, we can obtain the feedback fuzzy control law depending on the current state, xk, and the maximum delayed state vector, xk-d. It is shown that such a control law can locally stabilize the nonlinear discrete-time system at the origin. We also develop convex optimization procedures for the computation of the fuzzy control gains that maximize the estimates of the region of attraction. We present two examples to demonstrate the efficiency of the developed approach and to compare it with other approaches in the literature.

      • KCI등재

        Optimization of Production, Biochemical Characterization and In Vitro Evaluation of the Therapeutic Potential of Fibrinolytic Enzymes from a New Bacillus Amyloliquefaciens

        Fabiana América Silva Dantas de Souza,Amanda Emmanuelle Sales,Pablo Eugênio Costa e Silva,Raquel Pedrosa Bezerra,Germana Michelle de Medeiros e Silva,Janete Magali de Araújo,Galba Maria de Campos Taka 한국고분자학회 2016 Macromolecular Research Vol.24 No.7

        The capacity of fibrinolytic enzymes to degrade blood clots makes them of high relevance in medicine and in the pharmaceutical industry. In this work, forty-three microorganisms of the genus Bacillus were evaluated for their potential to produce fibrinolytic proteases. Thirty bacteria were confirmed as producers of fibrinolytic enzymes, the best results obtained for the strain Bacillus amyloliquefaciens UFPEDA 485. The optimization of the enzyme production conditions was done by a central composite design (CCD) star 23 that allowed to define the optimal conditions for soybean flour and glucose concentrations and agitation rate. The highest fibrinolytic activity (FA) of 813 U mL-1 and a degradation of blood clot in vitro of 62% were obtained in a medium with 2% (w/v) of soybean flour and 1% (w/v) glucose at 200 rpm after 48 h of cultivation, at pH 7.2 and 37 °C. The obtained fibrinolytic enzyme was characterized biochemically. Fibrinolytic activity was inhibited by PMSF (fluoride methylphenylsulfonyl - C7H7FO2S) 91.52% and EDTA (ethylenediaminetetraacetic acid - C10H16N2O8) 89.4%, confirming to be a serine- metallo protease. The optimum pH and temperature were 7.0 and 37 oC, respectively, and the enzyme was stable for 12 h. The fibrinolytic activity at physiological conditions of this enzyme produced by Bacillus amyloliquefaciens UFPEDA 485, as well as its long term stability, demonstrate that it has suitable characteristics for human and veterinary applications, and promises to be a powerful drug for the treatment of vascular diseases.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼